Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis.

[1]  Y. Kloog,et al.  Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) , 2007, Molecular Cancer Therapeutics.

[2]  G. Stamp,et al.  Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.

[3]  Levi A Garraway,et al.  Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. , 2007, Cancer research.

[4]  A. Cox,et al.  Geranylgeranyltransferase I as a target for anti-cancer drugs. , 2007, The Journal of clinical investigation.

[5]  R. Jaenisch,et al.  Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. , 2007, Genes & development.

[6]  Jun Wang,et al.  Knockdown of mutant K-ras expression by adenovirus-mediated siRNA inhibits the in vitro and in vivo growth of lung cancer cells , 2006, Cancer biology & therapy.

[7]  A. Balmain,et al.  A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice , 2006, Nature Genetics.

[8]  B. Gelb,et al.  Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. , 2006, American journal of human genetics.

[9]  Ming-Sound Tsao,et al.  K-ras mutations in non-small-cell lung carcinoma: a review. , 2006, Clinical lung cancer.

[10]  M. You,et al.  Prevention of lung cancer progression by bexarotene in mouse models , 2006, Oncogene.

[11]  J. Minna,et al.  Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , 2006, Cancer research.

[12]  D. Harrison,et al.  The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice. , 2006, Experimental cell research.

[13]  D. Harrison,et al.  K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. , 2006, Journal of experimental & clinical cancer research : CR.

[14]  J. Hancock,et al.  Ras signaling from plasma membrane and endomembrane microdomains. , 2005, Biochimica et biophysica acta.

[15]  J. Tichelaar,et al.  Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model. , 2005, Carcinogenesis.

[16]  Carmine Vecchione,et al.  Replacement of K‐Ras with H‐Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice , 2005, EMBO reports.

[17]  R. DePinho,et al.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.

[18]  R. Cardiff,et al.  Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.

[19]  R. Perez-soler,et al.  Complex effects of Ras proto-oncogenes in tumorigenesis. , 2003, Carcinogenesis.

[20]  J. Edwards,et al.  Detecting Changes in the Relative Expression of KRAS2 Splice Variants Using Polymerase Colonies , 2004, Biotechnology progress.

[21]  D. Harrison,et al.  While K-ras Is Essential for MouseDevelopment, Expression of the K-ras 4A Splice VariantIsDispensable , 2003, Molecular and Cellular Biology.

[22]  A. Wolfman,et al.  K-Ras Regulates the Steady-state Expression of Matrix Metalloproteinase 2 in Fibroblasts* , 2003, Journal of Biological Chemistry.

[23]  Manuel Serrano,et al.  Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.

[24]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[25]  Marshall W. Anderson,et al.  LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer , 2003, Oncogene.

[26]  T. Jacks,et al.  Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  H. Vikis,et al.  SmgGDS displays differential binding and exchange activity towards different Ras isoforms , 2002, Oncogene.

[28]  Falko Fend,et al.  Laser capture microdissection in pathology , 2000, Methods in enzymology.

[29]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[30]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[31]  S. Linn,et al.  Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene , 2001, Oncogene.

[32]  Ming You,et al.  Wildtype Kras2 can inhibit lung carcinogenesis in mice , 2001, Nature Genetics.

[33]  T. Jacks,et al.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.

[34]  M. You,et al.  Alternative splicing of the K-ras gene in mouse tissues and cell lines. , 2001, Experimental lung research.

[35]  A. Malkinson,et al.  DIFFERENTIAL SENSITIVITY TO LUNG TUMORIGENESIS FOLLOWING TRANSPLACENTAL EXPOSURE OF MICE TO POLYCYCLIC HYDROCARBONS, HETEROCYCLIC AMINES, AND LUNG TUMOR PROMOTERS , 2000, Experimental lung research.

[36]  R. Klemke,et al.  Four Human Ras Homologs Differ in Their Abilities to Activate Raf-1, Induce Transformation, and Stimulate Cell Motility* , 1999, The Journal of Biological Chemistry.

[37]  N. Hawkins,et al.  Developmentally-regulated expression of murine K-ras isoforms , 1997, Oncogene.

[38]  R. Kucherlapati,et al.  K-ras is an essential gene in the mouse with partial functional overlap with N-ras. , 1997, Genes & development.

[39]  L. Marton,et al.  Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. , 1997, Cancer research.

[40]  Marshall W. Anderson,et al.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Seeburg,et al.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations , 1983, Nature.